SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
笑傲江湖
Lv6
1840 积分
2022-01-13 加入
最近求助
最近应助
互助留言
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1天前
已完结
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
1个月前
已完结
-B6A: A New Vedotin Antibody-Drug Conjugate Directed to Integrin Beta-6 for Multiple Carcinoma Indications
1个月前
已完结
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
1个月前
已完结
Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy
1个月前
已完结
A B7-H4 targeting antibody-drug conjugate shows anti-tumor activity in PARPi and platinum resistant cancers with B7-H4 expression
2个月前
已完结
Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker
2个月前
已完结
Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker
2个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
2个月前
已完结
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled Study
2个月前
已完结
没有进行任何应助
点赞
1天前
速度真快
1个月前
点赞
1个月前
点赞
2个月前
仅需要补充材料,谢谢!
2个月前
速度真快
2个月前
速度真快
2个月前
速度真快
2个月前
感谢
2个月前
点赞
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论